Navistar International Stock Falls On Unusually High Volume (NAV)

NEW YORK ( TheStreet) -- Navistar International (NYSE: NAV) is trading at unusually high volume Thursday with 5.2 million shares changing hands. It is currently at four times its average daily volume and trading down $1.04 (-2.6%) at $38.99 as of 3:10 p.m. ET.

Navistar International has a market cap of $2.98 billion and is part of the consumer goods sector and automotive industry. Shares are up 5.7% year to date as of the close of trading on Wednesday.

Navistar International Corporation, through its subsidiaries, manufactures and sells commercial and military trucks, buses, diesel engines, recreational vehicles (RVs), and chassis, as well as provides service parts for trucks and trailers. The company has a P/E ratio of 1.7, below the average automotive industry P/E ratio of 1.9 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Navistar International as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, weak operating cash flow and poor profit margins. You can view the full Navistar International Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVDOWN to 95370 or select from multiple alert options.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing